Latest Content

Eflornithine Plus Gleostine Improves Progression, Survival In Some With Astrocytoma

November 23rd 2025, 2:00pm

By Kyle Doherty

Article

Eflornithine plus Gleostine was associated with superior overall survival and progression-free survival in grade 3 IDH-mutated astrocytoma.

B7-H3 CAR T-Cell Therapy Shows Acceptable Safety in Recurrent Glioblastoma

November 22nd 2025, 3:55pm

By Ashling Wahner

Article

Intraventricular B7-H3 CAR T-cell therapy was well tolerated up to 1 x 10⁷ cells per infusion and showed early signs of activity in recurrent glioblastoma.

Voranigo Plus Temodar Found to Be Safe in Patients With IDH1/2+ Glioma

November 22nd 2025, 3:45pm

By Chris Ryan

Article

Voranigo plus Temodar was safe in glioma with IDH1/2 mutations.

Gomekli Shows Early Activity in Pediatric Low Grade Glioma

November 22nd 2025, 2:10pm

By Ashling Wahner

Article

Early data from the SJ901 study show Gomekli generates responses with manageable side effects in children and young adults with low grade glioma.

Early Real-World Uptake of Voranigo in Patients With IDH-Mutant Glioma

November 21st 2025, 10:55pm

By Spencer Feldman

Article

Early data indicate Voranigo is rapidly being used in newly diagnosed and previously treated patients with IDH-mutant glioma, highlighting ongoing treatment needs.

Effective Early Treatments Needed in Glioma, Real-World Data Finds

November 21st 2025, 10:30pm

By Alex Biese

Article

Researchers identified a potential unmet need for an effective early treatment with minimal toxicity for patients with slow-growing IDH-mutant gliomas.

FDA Approves Keytruda and Padcev for Muscle Invasive Bladder Cancer

November 21st 2025, 5:49pm

By Spencer Feldman

Article

Keytruda and Padcev improve event-free and overall survival for adults with muscle invasive bladder cancer who cannot receive cisplatin after surgery.

Patient Advocate Shares Why The Future Is Bright For PV

November 21st 2025, 5:00pm

By Alex Biese

Article

In a recent interview with CURE, Nona Baker shared insights from her blood cancer journey that began more than 30 years ago.

Giredestrant Shows Benefit for Early Breast Cancer in Phase 3 Trial

November 21st 2025, 4:00pm

By Spencer Feldman

Article

Giredestrant improved invasive disease-free survival for people with estrogen receptor-positive early breast cancer compared with standard treatment.

Finding Grace in the Nurses Who Helped My Daughter Through Treatment

November 21st 2025, 2:29pm

By Debbie Legault

Article

I share how the nurses who cared for my daughter during chemotherapy brought comfort, connection and humanity that carried us through our hardest moments.

Immune-Based Combinations Are Reshaping Liver Cancer Treatment

November 20th 2025, 10:00pm

By Dr. Augusto Villanueva Rodriguez

Video

Immune-based therapies are transforming advanced liver cancer care, resulting in curative options previously considered unattainable.

Looking Back on a Blood Cancer Diagnosis Nearly 35 Years Later

November 20th 2025, 9:00pm

By Alex Biese

Video

Nona Baker received a diagnosis of essential thrombocythemia in 1991, followed by polycythemia vera in 2004.

Your Genes, Your Treatment: Biomarker Testing and Lung Cancer

November 20th 2025, 8:00pm

By Gina Mauro

Article

Dr. Anne Chiang explains how biomarker testing and molecular profiling personalize lung cancer treatment and compare tissue versus liquid biopsies.

Advice From a Cancer Survivor: Be Thankful

November 20th 2025, 6:00pm

By Brian Sluga

Article

After surviving testicular cancer, I feel like I was given a second chance at life. Although given challenges, I have learned to be resilient and face adversity head-on.

Breaking Down Gastrointestinal Stromal Tumor Basics

November 20th 2025, 5:00pm

By Alex Biese

Article

Dr. Ajay Gupta sat down with CURE to explain the basics of gastrointestinal stromal tumors, highlighting what patients with this disease need to know.